"Link ID","Source name","Source Display Name","Source type","Target name","Target Display Name","Target type","Confidence","Documents","Document IDs","Relationships"
"1","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](O)(=O)OCC(O)CO[P@](O)(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC","CARDIOLIPIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.08220708164428","7","Medline_8217481,Medline_14598587,Medline_26491702,Medline_8025204,Pmcoa_4603604,Medline_12121039,Medline_8027560","Association,Prepositional,AssociationPositive"
"2","F5","F5","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","79.76085783624006","5","Medline_19078479,Medline_22690563,Medline_11454529,Medline_12243558,Pmcoa_1936988","Prepositional"
"4","F3","F3","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","83.9248412112728","8","Medline_15456541,Medline_8420328,Medline_16385547,Medline_18827061,Medline_12730514,Medline_9031483,Pmcoa_3173726,Medline_19556010","Prepositional,GeneExpression,Regulation"
"5","F2","F2","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.33940093719002","11","Medline_9733155,Medline_9734636,Medline_17265495,Medline_22690563,Medline_23989738,Medline_11739542,Medline_22635224,Medline_12404033,Medline_19920091,Pmcoa_4691051,Medline_15751817","Prepositional,Association"
"6","CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O","WARFARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","91.71215224734944","19","Medline_25895847,Medline_13679527,Medline_14699652,Medline_8730144,Medline_14695423,Medline_14699650,Medline_8952760,Medline_15693072,Medline_17531168,Medline_20425536,Pmcoa_4286787,Medline_14699651,Medline_11705531,Medline_26905558,Medline_25104566,Medline_20704100,Medline_21606873,Medline_12322801,Medline_7933603","Prepositional,Treat"
"7","COC(=O)[C@@H](N1CCc2sccc2C1)c1ccccc1Cl","CLOPIDOGREL","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","81.40129095857945","2","Medline_10635651,Medline_8059174","Prepositional,Similarity"
"8","APOH","APOH","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","81.92134691988406","38","Medline_19706343,Medline_20876187,Medline_11019958,Medline_9825748,Pmcoa_4044026,Patent_WO2011022780A1,Pmcoa_1794526,Medline_15507263,Medline_15507279,Medline_24970589,Medline_12209489,Pmcoa_3987788,Pmcoa_3977461,Medline_21757614,Medline_8589206,Medline_12096042,Medline_10192506,Medline_9933445,Medline_14768953,Patent_US20150307581,Patent_US20130252887,Medline_23157457,Pmcoa_3328749,Pmcoa_3316958,Patent_US8993518,Medline_16539279,Pmcoa_4122060,Patent_US20090202980,Patent_US20070003552,Medline_17894014,Medline_15990076,Medline_16325497,Medline_12648080,Medline_16038107,Medline_9276526,Pmcoa_3273179,Medline_25733579,Medline_17265495","sialylation,Binding,Prepositional,AssociationPositive,Part_Of,Association,Regulation"
"9","GPI","GPI","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","80.06131402927672","17","Medline_10852267,Medline_20876187,Medline_21618459,Pmcoa_3523136,Medline_15762889,Medline_10680749,Medline_21535391,Medline_17332980,Medline_10563468,Patent_WO2007008069A2,Patent_US20080207488,Patent_EP1910844B1,Patent_EP1910842A2,Patent_EP2386861A2,Patent_US20080118529,Patent_US20080267948,Medline_19758240","Prepositional,Binding,Association,AssociationPositive,AssociationNegative"
"10","CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O","PLATELET ACTIVATING FACTOR","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","68.20795712862979","4","Patent_WO2009056826A1,Medline_10886305,Patent_EP2217280A1,Patent_US20100278836","Prepositional"
"12","CC(=O)Oc1ccccc1C(O)=O","ASPIRIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","91.3496567501396","15","Pmcoa_2679410,Medline_8373524,Medline_20502298,Medline_10649166,Pmcoa_3977461,Medline_8371226,Medline_18308578,Medline_21640048,Medline_8160462,Medline_20676893,Medline_18089677,Medline_7804312,Medline_24200687,Medline_7933603,Medline_18043834","Prepositional,Treat,AssociationNegative,Association"
"13","CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](O)O[C@H](O[C@H]3[C@H](O)[C@@H](OS(O)(=O)=O)C(O)O[C@H]3C(O)=O)[C@H](OS(O)(=O)=O)[C@H]2CS(O)(=O)=O)O[C@@H]1C(O)=O","HEPARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","92.70093028681856","32","Pmcoa_3359668,Medline_12661774,Medline_18275516,Pmcoa_3764119,Medline_22122183,Medline_12833567,Pmcoa_3977461,Medline_20859172,Medline_20502298,Medline_22635233,Medline_21640048,Pmcoa_3880751,Medline_21206127,Medline_23899550,Medline_19716166,Medline_11711550,Patent_EP2357257A1,Patent_US20070020647,Patent_US20130296255,Patent_US20090258822,Patent_US20090124542,Patent_US20090247451,Patent_US7745389,Patent_US8088579,Patent_EP2377951A1,Patent_EP2357254A1,Patent_EP2302076A1,Patent_US8497350,Medline_15489858,Medline_11898913,Medline_7933603,Medline_18043834","RegulationPositive,Prepositional,Binding,Treat,Association,AssociationNegative,Regulation"
"14","CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O","TADALAFIL","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","65.99504498086442","2","Pmcoa_4652825,Medline_26579816","Prepositional"
"15","RITUXIMAB","RITUXIMAB","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","92.84117538665642","11","Medline_21993385,Medline_20425532,Pmcoa_4661911,Medline_12967521,Medline_25148947,Medline_23740031,Medline_23777822,Medline_18089684,Medline_24179505,Pmcoa_3813804,Medline_16465669","Prepositional,Treat"
"19","CC(C)C(C)C=CC(C)C1CCC2\C(CCCC12C)=C\C=C1CC(O)CCC1=C","VITAMIN D","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","81.06818513643476","3","Pmcoa_4363976,Medline_25686077,Medline_20980705","Prepositional"
"21","TNF","TNF","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.76284721480505","8","Medline_25869505,Medline_11246532,Medline_12892396,Patent_WO2004080273A2,Patent_US20060193863,Patent_EP1601682B1,Patent_EP1601682A2,Medline_20337548","Treat,Prepositional,AssociationNegative,AssociationPositive"
"23","Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O","RIVAROXABAN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","87.42814950250319","4","Medline_25923780,Pmcoa_4452246,Medline_25850997,Pmcoa_4527976","TREAT,Prepositional,Regulation"
"26","F12","F12","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.39779795417729","5","Medline_10997986,Medline_15869593,Medline_11916074,Pmcoa_1322227,Medline_16324213","Prepositional"
"30","ANXA5","ANXA5","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.5552060822201","4","Medline_10522297,Medline_11108960,Medline_24600987,Medline_25511578","AssociationNegative,Prepositional"
"33","ECULIZUMAB","ECULIZUMAB","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","84.5646853944065","4","Pmcoa_4157546,Pmcoa_4179587,Medline_24400968,Pmcoa_3487299","Prepositional,AssociationNegative"
"35","DALTEPARIN","LOW MOLECULAR WEIGHT HEPARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","84.30365117050994","15","Medline_18308578,Pmcoa_3274119,Medline_16412749,Patent_US7745389,Patent_EP2357257A1,Patent_US20070020647,Patent_EP2302076A1,Patent_US20090124542,Patent_US8088579,Patent_EP2357254A1,Patent_US20090258822,Patent_US8497350,Patent_US20090247451,Patent_US20130296255,Patent_EP2377951A1","Prepositional,Treat,AssociationNegative"
"36","ANXA2","ANXA2","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","76.5206417812914","4","Pmcoa_3634455,Medline_20229030,Medline_22939813,Medline_18322784","Prepositional"
"44","C5AR1","C5AR1","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","77.67784309110016","6","Patent_EP2340028A1,Patent_US20110269113,Patent_US8445190,Patent_WO2015004038A1,Patent_WO2010039690A1,Medline_20005073","Regulation,Prepositional"
"47","IGHM","IGHM","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","82.56169406088463","2","Medline_24761704,Medline_24075882","Change,Similarity"
"49","SELP","SELP","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","77.17135133589878","3","Medline_12911278,Pmcoa_4454049,Medline_25541651","Prepositional"
"51","PROC","PROC","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.17122934848992","3","Medline_22290026,Medline_25196808,Pmcoa_4417204","Prepositional"
"53","F10","F10","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","77.87538780983378","5","Pmcoa_4365552,Medline_25864630,Medline_25890027,Medline_17114499,Medline_8578503","Prepositional"
"58","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O","EPOPROSTENOL","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","80.11251101330096","2","Medline_3296970,Medline_8315831","Prepositional"
"63","CD79A","CD79A","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","79.22363286077582","3","Medline_9646856,Medline_24075882,Pmcoa_4003762","Prepositional,Similarity"
"88","IS4","IS4","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","2.041514248805465","2","Patent_US20110318360,Patent_US20110305700","Prepositional"
